Zentalis Pharma CEO Change
Zentalis Pharmaceuticals announces executive change, updates compensatory arrangements for certain officers. Filing reveals changes in leadership.
Filed: 2026-05-27 AccNo: 0001725160-26-000049 Size: 163 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers